Evan Vosburgh

Evan Vosburgh, MD is an Associate Clinical Professor of Medicine at Yale School of Medicine, specializing in Medical Oncology and Hematology. He provides clinical care at the West Haven Veterans Hospital and serves as a primary care attending at the Yale Primary Care Center Wednesday Evening Clinic. Dr. Vosburgh is affiliated with Yale Cancer Center and participates in the Cancer Signaling Networks research program.

Dr. Vosburgh's research interests focus on neuroendocrine cancers, amyloidosis, and clotting disorders. His work has significantly contributed to understanding neuroendocrine tumor biology, particularly pancreatic neuroendocrine tumors, through the development and analysis of mouse models. He has investigated genetic factors in tumor development, including the cooperative effects of tumor suppressor gene deletions and the role of specific alleles in determining tumor types.

His publication record shows consistent contributions to the field since the early 2000s, with recent work (2017-2022) focusing on comprehensive reviews of neuroendocrine and gastroenteropancreatic system tumors. Earlier research (2010-2016) examined genetic mechanisms, sexual dimorphism in metastasis, and innovative approaches to tumor analysis.

Dr. Vosburgh maintains active membership in major professional organizations including the American Association of Cancer Research, American Society of Clinical Oncology, and American Society of Hematology.

His clinical work at the Veterans Hospital and Yale Primary Care Center demonstrates a commitment to both specialized oncology care and general medical practice. Dr. Vosburgh's dual focus on research and clinical care positions him as a valuable contributor to both academic medicine and patient care.